ENTEST BIOMEDICAL, INC.
Entest BioMedical, Inc. currently trades on the OTC Bulletin Board under the symbol: “ENTB”.The Company was formed in April 2009 and is majority-owned by Bio-Matrix Scientific Group, Inc. (OTC BB: BMSN).
Key Personnel
David R. Koos, PhD, DBA – Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD – Director of Research
Marilyn Panahi – Director of Quality Assurance
Investment Highlights
The Company’s seasoned management has a proven history of entrepreneurship and a successful track record of founding and operating development stage public biotechnology companies.
The Company has assembled an expert and experienced scientific team with extensive networks who can quickly forge strategic alignments and partnerships in its R & D areas of focus
Contact Information
David R. Koos,
Chairman and CEO
Entest BioMedical, Inc.
4700 Spring Street, Suite 203
La Mesa, Calif. 91942
Telephone: 619-702-1404
Fax: 619-330-2328
E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Web site: www.EntestBio.com
|
